We are live on
!
Find out more
ADC Therapeutics
ADCT
ADCT
115 hedge funds and large institutions have $293M invested in ADC Therapeutics in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,771% more call options, than puts
Call options by funds: $131K | Put options by funds: $7K
78% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 27
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
8% more funds holding
Funds holding: 106 → 115 (+9)
8% more capital invested
Capital invested by funds: $271M → $293M (+$21.5M)
6.6% more ownership
Funds ownership: 60.3% → 66.89% (+6.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
115
Holders Change
+9
Holders Change %
+8.49%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
21
Increased
48
Reduced
27
Closed
12
Calls
$131K
Puts
$7K
Net Calls
+$124K
Net Calls Change
+$327K
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.7M |
| 2 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$5.3M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.73M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.12M |
| 5 |
Millennium Management
New York
|
-$1.51M |
